These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31261497)

  • 1. Prednisone is not beneficial for the treatment of severe drug-induced liver injury: An observational study (STROBE compliant).
    Wan YM; Wu JF; Li YH; Wu HM; Wu XN; Xu Y
    Medicine (Baltimore); 2019 Jun; 98(26):e15886. PubMed ID: 31261497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of corticosteroids for patients with severe drug-induced liver injury.
    Hu PF; Wang PQ; Chen H; Hu XF; Xie QP; Shi J; Lin L; Xie WF
    J Dig Dis; 2016 Sep; 17(9):618-627. PubMed ID: 27426618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury.
    Wree A; Dechêne A; Herzer K; Hilgard P; Syn WK; Gerken G; Canbay A
    Digestion; 2011; 84(1):54-9. PubMed ID: 21304237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
    Suzuki N; Noh JY; Hiruma M; Kawaguchi A; Morisaki M; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Iwaku K; Yoshihara A; Watanabe N; Sugino K; Ito K
    Thyroid; 2019 Oct; 29(10):1390-1398. PubMed ID: 31573408
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
    Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
    J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury.
    Jeong R; Lee YS; Sohn C; Jeon J; Ahn S; Lim KS
    Scand J Gastroenterol; 2015 Apr; 50(4):439-46. PubMed ID: 25639449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study.
    Chen SS; Yu KK; Huang C; Li N; Zheng JM; Bao SX; Chen MQ; Zhang WH
    Medicine (Baltimore); 2016 Aug; 95(34):e4683. PubMed ID: 27559976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Alcoholic hepatitis and corticosteroids.
    Leevy CM; Zetterman R
    Ann Intern Med; 1973 Nov; 79(5):739-40. PubMed ID: 4751745
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
    Colombel JF; Panaccione R; Bossuyt P; Lukas M; Baert F; Vaňásek T; Danalioglu A; Novacek G; Armuzzi A; Hébuterne X; Travis S; Danese S; Reinisch W; Sandborn WJ; Rutgeerts P; Hommes D; Schreiber S; Neimark E; Huang B; Zhou Q; Mendez P; Petersson J; Wallace K; Robinson AM; Thakkar RB; D'Haens G
    Lancet; 2017 Dec; 390(10114):2779-2789. PubMed ID: 29096949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased red cell distribution width predicts severity of drug-induced liver injury: a retrospective study.
    Li X; Xu H; Gao P
    Sci Rep; 2021 Jan; 11(1):773. PubMed ID: 33436893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
    Church RJ; Watkins PB
    Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial.
    Campra JL; Hamlin EM; Kirshbaum RJ; Olivier M; Redeker AG; Reynolds TB
    Ann Intern Med; 1973 Nov; 79(5):625-31. PubMed ID: 4751740
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for liver injury with an elevated serum bilirubin concentration caused by antituberculous drugs.
    Kato H; Horita N; Miyazawa N; Yoshiyama T; Ueda A; Ishigatsubo Y
    Intern Med; 2013; 52(19):2209-14. PubMed ID: 24088753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisone in the treatment of tubulointerstitial nephritis in children.
    Jahnukainen T; Saarela V; Arikoski P; Ylinen E; Rönnholm K; Ala-Houhala M; Nuutinen M
    Pediatr Nephrol; 2013 Aug; 28(8):1253-60. PubMed ID: 23605375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum proteomic profiling in patients with drug-induced liver injury.
    Bell LN; Vuppalanchi R; Watkins PB; Bonkovsky HL; Serrano J; Fontana RJ; Wang M; Rochon J; Chalasani N;
    Aliment Pharmacol Ther; 2012 Mar; 35(5):600-12. PubMed ID: 22403816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI.
    Ashby K; Zhuang W; González-Jimenez A; Alvarez-Alvarez I; Lucena MI; Andrade RJ; Aithal GP; Suzuki A; Chen M
    J Hepatol; 2021 Aug; 75(2):333-341. PubMed ID: 33845060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid therapy in drug-induced liver injury: Pros and cons.
    Hu PF; Xie WF
    J Dig Dis; 2019 Mar; 20(3):122-126. PubMed ID: 30582289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.